Scott at the moment there is no pathway to register a simple 1:1...

First 21 Last

Share
Profile

Follow
Ozibobby

994 Posts.

303

31/10/21

18:23

Post #: 57214062
Share

Originally posted by Scott th Ratbag: ↑

"one I think will reward patience if they stay on track.". ....... yet the track has changed once again.

previous tracks were focused on developing a pharmaceutical formulation which would be of use for humans in medical distress, when other medications have difficult to cope with adverse events there was/is a clear need to pharmaceutical grade cannabis which can/do provide relief.

Auscann had this which is now relegated to "compassionate use of unregistered medicines". (Layton Mills words)

why has Neuvis been so abandoned? Why has registration with the TGA been dropped? Mills does not address these points. He has done a Morrison by using strategic argument to distract from and so avoid the real issue.

Until the reverse acquisition of Cannpal, as you might be aware, I was a fervent supporter of Auscann. We had an opportunity to be the first Aus made pharmaceutical quality preparation to be registered and authorised for a diverse range of applications. We should not be receiving revenue for prescriptions across Tasmania at least and across the nation via TGA approval.

what has happened since Cannpal took over? zilch.

the only product that is important now is a treatment for dogs.

Expand

Scott at the moment there is no pathway to register a simple 1:1 ratio medication containing THC for a general indication. The only pathway at the moment is for CBD . What Layton is doing is exactly what you say you bought into at AusCann originally. When Ido was talking his game on Neuvis he was banking on regulatory change that never happened. Looking at specific needs and running specific trials on specific formulations is the pathway.

AC8 Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASM

ASM to push Dubbo REE play towards economical production with A$5M Federal govt grant

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

Wealth Within: the latest stock tips from Dale Gillham

A1G

African Gold finds significant 5.5g/t intercept over 65m in Cote d’Ivoire